Vor Bio's Transition Into Clinical Trials

By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein

No company can stand still and simply exist. A healthy company must move ahead, one step at a time. Small steps add up to big ones, and the big steps become a leap forward, a transition that transforms the company.

Beyond the formative beginnings, moving on from theories into proven concepts and working models, the first true transition for a biopharma company carries it out of the laboratory and into larger and larger groups of courageous patients offering their own bodies as the ultimate testing grounds. The first of several stages in the escalating size and scope of human trials marks the great transition into Phase 1 clinical studies.